InvestorsHub Logo
Followers 57
Posts 11404
Boards Moderated 0
Alias Born 02/09/2009

Re: joball post# 23770

Monday, 11/23/2015 4:47:44 PM

Monday, November 23, 2015 4:47:44 PM

Post# of 30990
2015-11-09 Patent: Anatabine for Autism Spectrum and Seizure Disorders

This was unexpected and in my opinion, a good sign.

http://investors.rockcreekpharmaceuticals.com/2015-11-09-Rock-Creek-Pharmaceuticals-Announces-European-Patent

Rock Creek Pharmaceuticals Announces European Patent Allowance for the Administration of Anatabine to Treat Autism Spectrum and Seizure Disorders and Third Quarter Results

SARASOTA, Fla., Nov. 9, 2015 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (OTCPK: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions, announced today its third quarter results. The Company also disclosed the Notification of Intent to Grant by the European Patent Office of a European patent for the administration of Anatabine to treat autism spectrum and seizure disorders.

More at above link ...
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.